Related Experiment Videos
Ten years of experience with 1,000 hyperactive children in a private practice
Insights
Stimulant medication is a safe and effective treatment for hyperactive children, with 84% showing positive responses. Long-term treatment, often 5–10 years, helps manage symptoms during challenging developmental periods.
Area of Science:
- Pediatrics
- Child Psychology
- Pharmacology
Background:
- Hyperactivity in children is a significant concern requiring effective management strategies.
- Stimulant medications are commonly prescribed for attention deficit hyperactivity disorder (ADHD).
Purpose of the Study:
- To summarize clinical experience with stimulant treatment in a large cohort of hyperactive children.
- To evaluate the efficacy, safety, and duration of stimulant therapy for childhood hyperactivity.
Main Methods:
- Retrospective analysis of 1,000 hyperactive children treated over 10 years.
- Assessment of treatment response, failure rates, and long-term outcomes in children receiving stimulant medication for over 6 months.
Main Results:
- 84% of 872 treated children showed a positive response to stimulant medication.
- 16% of children were considered treatment failures; 20% experienced symptom relapse after remission.
- Treatment duration varied, with many boys treated 3-5 years and girls 2-3 years; 20% received medication for over 6 years.
Conclusions:
- Long-term stimulant treatment (5-10 years) is safe and effective for hyperactive children.
- Stimulant therapy can help manage symptoms during critical developmental phases.
- Careful monitoring is essential to manage potential symptom recurrence and optimize treatment duration.
Abstract:
A summary of the author's experience with 1,000 hyperactive children treated in a private practice over a period of 10 years is presented. Of 1,000 children entering the office, 872 were treated with stimulants for more than 6 months. Of these 872 children, 137 (16%) were considered as treatment failures; 735 (84%) had a positive response to medication. A follow-up of 197 patients in "remission," after treatment, suggested that symptoms had reappeared in 20% of the cases. The length of treatment in a group of 494 children still under observation on Dec 31, 1981, indicated that the majority of boys were treated for between 3 to 5 years; girls were treated for 2 to 3 years. Approximately 10% of the children received medication for 1 to 2 years, whereas about 20% were treated for more than 6 years. It was concluded that treatment with a stimulant for 5 to 10 years is a safe and efficient way to help hyperactive children during a difficult time of life.